Analysis Note
ControlHeLa cell lysate treated with interferon gamma.
Application
Research CategoryNeuroscience
Anti-IDO Antibody, clone 1F8.2 is an antibody against IDO for use in WB, IH.
Research Sub CategoryOxidative Stress
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
General description
Indoleamine 2,3-dioxygenase (IDO) is an enzyme that is responsible for converting tryptophan to kynurenines. IDO is expressed by a wide variety of tissues and IDO can be upregulated by interferon gamma. IDO modulates levels of the amino acid tryptophan, which is vital for cell growth, but is also involved in the suppression of the immune response. IDO may be involved in the
suppression of the immune response to tumours and blocking the IDO pathway may be a potential target for immunotherapy.
Immunogen
GST-tagged recombinant protein of full-length human IDO.
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Physical form
Protein G Purified
Format: Purified
Mouse monoclonal in buffer containing 0.1 M Tris-glycine, pH 7.4, 150 mM NaCl and 0.05% sodium azide.
Quality
Evaluated by Western Blot in HeLa cell lysate.
Western Blot Analysis: 0.1 µg/mL dilution of this antibody detected IDO on 15 µg of HeLa cell lysate.
Specificity
This antibody recognizes IDO.
Storage and Stability
Maintain refrigerated at 2-8°C for 1 year from date of receipt.
Target description
Approx. 45 kDa
This product has met the following criteria to qualify for the following awards: